SCYNEXIS, Inc. Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss
SCYNEXIS, Inc. (SCYX) had Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss of $64.00 thousand as of 2023-03-31, per its 10-Q filed 2023-05-10.
Discontinued › Notes › Debt and Equity Securities › Debt Securities, Held-to-Maturity, Fair Value to Amortized Cost, after Allowance for Credit Loss
us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss · last filed 2023-05-10
- 2023-03-31: Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss $64.00K.
- 2022-12-31: Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss $160.00K.
- 2022-09-30: Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss $164.00K.
- 2020-06-30: Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss $0.00.
| Period end | Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss |
|---|---|
| 2023-03-31 | $64.00K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $160.00K 10-Q · filed 2023-05-10 |
| 2022-09-30 | $164.00K 10-Q · filed 2022-11-09 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-10 |
| 2020-03-31 | $15.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $14.00K 10-K · filed 2021-03-29 |
| 2019-09-30 | $10.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $6.00K 10-Q · filed 2019-08-07 |
| 2019-03-31 | $4.00K 10-Q · filed 2019-05-08 |
| 2018-12-31 | $15.00K 10-K · filed 2020-03-11 |
| 2018-09-30 | $12.00K 10-Q · filed 2018-11-13 |
| 2018-06-30 | $5.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $6.00K 10-Q · filed 2018-05-08 |
| 2017-12-31 | $79.00K 10-K · filed 2019-03-14 |
| 2017-09-30 | $74.00K 10-Q · filed 2017-11-07 |
| 2017-06-30 | $73.00K 10-Q · filed 2017-08-08 |
| 2017-03-31 | $70.00K 10-Q · filed 2017-05-08 |
| 2016-12-31 | $62.00K 10-K · filed 2017-03-13 |
| 2016-09-30 | $48.00K 10-Q · filed 2016-11-07 |
| 2016-06-30 | $8.00K 10-Q · filed 2016-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |